ANKRD27-SLC7A9 Fusion FISH Probe
The ANKRD27-SLC7A9 Fusion FISH Probe is used to confirm a fusion of the ANKRD27 and SLC7A9 genes. The fusion of the ANKRD27 and SLC7A9 genes has been associated with Uterine Corpus Endometrial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ANKRD27-SLC7A9-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ANKRD27-SLC7A9-20-AQAQ | 20 (40 μL) | 200 μL |
|
SLC7A9 Gene Summary
This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011]
Gene Name: Solute Carrier Family 7 Member 9
Chromosome: CHR19: 33321418 -33360683
Locus: 19q13.11
ANKRD27 Gene Summary
The Ankyrin Repeat Domain 27 (ANKRD27) gene is located on chr19 :33087906-33166102 at 19q13.11.
Gene Name: Ankyrin Repeat Domain 27
Chromosome: CHR19: 33087906 -33166102
Locus: 19q13.11
Gene Diseases
The ANKRD27 SLC7A9 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Uterine Corpus Endometrial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|